Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
---|
06/01/2010 | CA2367671C Process for the preparation of the polymorph a of doxazosin mesylate |
05/27/2010 | WO2010058060A1 Aryl piperazine and their use as alpha2c antagonists |
05/27/2010 | WO2010019911A3 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
05/27/2010 | US20100130753 Catalysts for the polymerization of cyclic esters |
05/27/2010 | US20100130458 Polymorphs of fluticasone furoate and process for preparation thereof |
05/27/2010 | US20100127211 Five-ring liquid crystal compound having cf20 bonding group, liquid crystal composition, and liquid crystal display device |
05/27/2010 | CA2741986A1 Method and apparatus for manure treatment |
05/26/2010 | EP2188282A2 1,2-diamido-ethylene derivatives as orexin antagonists |
05/26/2010 | CN201482237U Recrystallization purification device for lactide |
05/26/2010 | CN1746168B Optically active doxazosin |
05/26/2010 | CN101239966B Method for preparing annular aliphatic carbonic ester containing cinnamoyloxy group and polymers thereof |
05/26/2010 | CN101134752B Chemical method for synthesizing carisoprodol key intermediate compound |
05/25/2010 | US7723536 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
05/25/2010 | CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials |
05/20/2010 | WO2010017094A3 CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING |
05/20/2010 | WO2009060832A9 Apparatus and method both relating to polymer synthesis |
05/19/2010 | EP2185713A2 Process for preparing chiral compounds |
05/19/2010 | CN101204401B Sea hedgehog extractive, preparation method and anticancer application thereof |
05/18/2010 | US7718812 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivates |
05/14/2010 | WO2010053275A2 Method for preparing (3s,4s)-4-((r)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor |
05/14/2010 | CA2741690A1 Method for preparing (3s,4s)-4-((r)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor |
05/13/2010 | US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production |
05/12/2010 | EP2183238A1 Process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof |
05/12/2010 | DE19918009B4 Fluorierte Cyclohexan-Derivate und flüssigkristallines Medium Fluorinated cyclohexane derivatives and liquid crystalline medium |
05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
05/11/2010 | US7713939 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; -cell leukemia, B-cell lymphoma, myeloma, T-cell leukemia, T-cell lymphoma, small leukemia, and small cell lymphoma |
05/11/2010 | CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
05/06/2010 | WO2010048715A1 Gemini surfactants |
05/06/2010 | WO2010022966A8 Process for preparing a mixture of lactide derivatives |
05/06/2010 | US20100113806 Production of cyclic diesters of alpha-hydroxyacids |
05/06/2010 | US20100112482 Fluorinated monomer of cyclic acetal structure, polymer, resist protective coating composition, resist composition, and patterning process |
05/06/2010 | CA2741697A1 Gemini surfactants |
05/05/2010 | EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections |
05/05/2010 | CN1960982B Method for separating 1,3-dioxolan-4,6-dione compound |
05/05/2010 | CN1903857B Method of synthesizing high purity 1,3:2,4-di (3,4-dimethyl) benzyl cross sorbic alcohol |
05/05/2010 | CN1769285B Doxazosin salt with optical activity |
05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
04/29/2010 | WO2010046194A1 Novel herbicides |
04/29/2010 | US20100104950 Fluorinated compounds for use in lithium battery electrolytes |
04/29/2010 | CA2738752A1 Novel herbicides |
04/28/2010 | CN1777568B Process for manufacture of an allyl ether |
04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
04/22/2010 | WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
04/22/2010 | WO2010043581A1 Method and catalysts for producing cyclic carbonates |
04/22/2010 | WO2010003624A3 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
04/22/2010 | US20100099894 Method for the Synthesis of Cyclic Acetals by the Reactive Extraction of a Polyol in a Concentrated Solution |
04/22/2010 | US20100099893 Purification of lactide rich streams |
04/22/2010 | CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
04/21/2010 | EP2176245A2 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses |
04/21/2010 | CN101696204A Purification method of lactide |
04/21/2010 | CN101696203A Method for continuously refining L-lactide from crude L-lactide |
04/20/2010 | US7700522 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
04/15/2010 | WO2010042600A2 Photo-activatable therapeutic agents and methods of using |
04/15/2010 | WO2010041670A1 Diolefin compound, epoxy resin, curable resin composition and cured product |
04/15/2010 | US20100093707 Acid amide derivatives, process for their production and pesticides containing them |
04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
04/14/2010 | CN101092410B Method and equipment for preparing cyclic trimethylolpropane formal by using heavy residue of trimethylolpropane |
04/13/2010 | CA2408004C Process for the preparation of dihydroxy esters and derivatives thereof |
04/08/2010 | WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
04/08/2010 | US20100087517 Prodrugs of substituted 1,3-dioxanes and their uses |
04/08/2010 | DE102007010077B4 [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren [1,3] -Dioxane for modulation of GABAa receptors |
04/08/2010 | CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
04/07/2010 | EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
04/06/2010 | US7692033 Process for producing 2-benzoyloxyacetaldehyde derivative |
04/01/2010 | WO2010036884A1 Ketal ester derivatives |
04/01/2010 | CA2736636A1 Ketal ester derivatives |
03/31/2010 | EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
03/31/2010 | EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
03/31/2010 | EP1807393B1 Diarylsulfones as 5-ht2a antagonists |
03/30/2010 | US7687665 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor |
03/24/2010 | EP2166000A1 7-, 8- and 9-substituted tetracycline compounds |
03/24/2010 | CN101679370A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
03/24/2010 | CN101676289A A method for preparing ascaridole |
03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
03/23/2010 | US7683096 Acid amide derivatives, process for producing these, and pest control agent containing these |
03/17/2010 | EP1783123B1 Synthesis of polyoxygenated nitrogen systems, comprising reactions between enamines of 1,3-dioxan-5-ones and nitroolefins |
03/17/2010 | CN100594213C N-[2-(5,5-dimethyl-1,3-dioxan-2-yl)-ethyl]amino acid and its synthesis and application |
03/16/2010 | US7680601 Generating antibiotic; transforming cell with expression vector coding polyketide synthase; computational analysis of polyketides and computer-assisted design of PKS genes are facilitated by representing structure of polyketide and/or PKS gene that encodes PKS that produces polyketide |
03/11/2010 | WO2009147632A3 New compounds for the treatment of cancer |
03/11/2010 | US20100063138 Novel substituted sulfamide derivatives |
03/10/2010 | EP2161263A1 Method for storing and transporting cyclical diesters |
03/04/2010 | WO2010023448A1 Novel potassium channel blockers |
03/04/2010 | WO2010022966A2 Process for preparing a mixture of lactide derivatives |
03/04/2010 | US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof |
03/04/2010 | US20100056588 Histone deacetylase inhibitors |
03/04/2010 | CA2734102A1 Method for the production of a mixture of lactide derivatives |
03/03/2010 | EP2159221A1 Glucagon receptor antagonists, preparation and therapeutic uses |
03/03/2010 | CN101659651A Method for preparing natural equivalent 3-hydroxyl-2-butanone dimer flavor |
03/02/2010 | US7671075 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
02/25/2010 | WO2010021093A1 Asymmetric organic catalyst |
02/25/2010 | WO2010020548A1 Glyt1 receptor antagonists |
02/25/2010 | WO2010020370A1 Method for storing and transporting cyclic diesters |
02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
02/24/2010 | EP2155736A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |